Huntington National Bank Abbott Laboratories Transaction History

Huntington National Bank

$13.5 Billion
Q3 2024

A detailed history of Huntington National Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Huntington National Bank holds 436,054 shares of ABT stock, worth $57.3 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

436,054

Previous 444,293 1.85%

Holding current value

$57.3 Million

Previous $46.2 Million 7.69%

% of portfolio

0.37%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$100.07 - $118.13 $824,476 - $973,273	-8,239 Reduced 1.85%	436,054 $49.7 Million
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $1.77 Million - $1.98 Million	-17,582 Reduced 3.81%	444,293 $46.2 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $828,847 - $915,425	-7,568 Reduced 1.61%	461,875 $52.5 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $5.31 Million - $6.5 Million	-58,880 Reduced 11.14%	469,443 $51.7 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $739,402 - $887,158	-7,740 Reduced 1.44%	528,323 $51.2 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $262,229 - $292,178	-2,602 Reduced 0.48%	536,063 $58.4 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $1.25 Million - $1.47 Million	-12,911 Reduced 2.34%	538,665 $54.5 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $977,216 - $1.15 Million	-10,280 Reduced 1.83%	551,576 $60.6 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $1.58 Million - $1.83 Million	-16,367 Reduced 2.83%	561,856 $54.4 Million
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $336,728 - $406,997	-3,299 Reduced 0.57%	578,223 $62.8 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $251,072 - $306,166	-2,202 Reduced 0.38%	581,522 $68.8 Million
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $334,805 - $409,951	-2,898 Reduced 0.49%	583,724 $82.2 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $780,922 - $863,927	6,694 Added 1.15%	586,622 $69.3 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $8.42 Million - $9.91 Million	79,570 Added 15.9%	579,928 $67.2 Million
Q1 2021 Apr 12, 2021	SELL	$108.84 - $128.23 $1.27 Million - $1.5 Million	-11,688 Reduced 2.28%	500,358 $60 Million
Q4 2020 Jan 11, 2021	SELL	$105.0 - $114.42 $612,465 - $667,411	-5,833 Reduced 1.13%	512,046 $56.1 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $1.01 Million - $1.22 Million	-10,972 Reduced 2.07%	517,879 $56.4 Million
Q2 2020 Jul 30, 2020	SELL	$76.57 - $98.0 $218,683 - $279,888	-2,856 Reduced 0.54%	528,851 $48.4 Million
Q1 2020 Apr 27, 2020	SELL	$62.82 - $91.86 $627,823 - $918,048	-9,994 Reduced 1.84%	531,707 $42 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $2.31 Million - $2.58 Million	-29,467 Reduced 5.16%	541,701 $47.1 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $2.46 Million - $2.67 Million	30,086 Added 5.56%	571,168 $47.8 Million
Q2 2019 Jul 23, 2019	SELL	$72.88 - $85.0 $2.4 Million - $2.8 Million	-32,959 Reduced 5.74%	541,082 $45.5 Million
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $1.97 Million - $2.38 Million	-29,777 Reduced 4.93%	574,041 $45.9 Million
Q4 2018 Jan 28, 2019	SELL	$65.56 - $74.27 $332,389 - $376,548	-5,070 Reduced 0.83%	603,818 $43.7 Million
Q3 2018 Oct 18, 2018	BUY	$60.81 - $73.36 $432,541 - $521,809	7,113 Added 1.18%	608,888 $44.7 Million
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $498,210 - $549,875	-8,654 Reduced 1.42%	601,775 $36.7 Million
Q1 2018 Apr 30, 2018	BUY	$56.27 - $63.62 $38,151 - $43,134	678 Added 0.11%	610,429 $36.6 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $182,404 - $195,283	-3,398 Reduced 0.55%	609,751 $34.8 Million
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $29.5 Million - $32.9 Million	613,149	613,149 $32.7 Million

Others Institutions Holding ABT

# of Institutions

3,265

Shares Held

1.31B

Call Options Held

9.64M

Put Options Held

8.27M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Abbott Laboratories Transaction History